BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:27 PM
May 23, 2008
 |  BC Extra  |  Top Story

JapanBridge in-licenses Sancuso

Japanese specialty pharma company JapanBridge (Tokyo, Japan) in-licensed its first product, Sancuso granisetron, from ProStrakan (LSE:PSK). The deal gives JapanBridge exclusive rights to develop and commercialize the transdermal anti-emetic patch in Japan, China...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >